NSE · JUBLPHARMA.NS
Jubilant Pharmova Limited
₹925.10-₹20.90 (-2.21%)
Jubilant Pharmova Limited’s quoted price sits in the lower half of its reported 52-week range, 21.8% below the high.
Loading market information…
NSE · INNOVACAP.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Innova Captab Limited’s quoted price sits in the upper half of its reported 52-week range, 23.85% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Innova Captab Limited’s next earnings report is currently expected on Nov 6, 2026, with estimated earnings per share of ₹8.00. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Innova Captab Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Innova Captab Limited, established in Panchkula, India, in 2005, operates as a comprehensive pharmaceutical enterprise. Its operations encompass the full spectrum of drug development, from research and development and manufacturing to distribution and marketing, serving both domestic and international markets. The company also extends Contract Development and Manufacturing Organization (CDMO) services to other pharmaceutical businesses within India. Furthermore, Innova Captab is actively involved in developing, producing, and supplying a diverse array of generic medications. These formulations address a broad range of therapeutic areas, including anti-infectives (such as cephalosporins and antivirals), gastrointestinal treatments (like proton pump inhibitors and antiemetics), pain and inflammation management (including NSAIDs and analgesics), respiratory and allergy relief, cardiovascular support, antidiabetics, various neurological and psychiatric therapies, and solutions for urological conditions, among numerous other specialized segments. These pharmaceutical offerings are provided in multiple forms, such as tablets, capsules, dry syrups, injectable powders, ointments, and liquid oral preparations. Innova Captab distributes its branded generic products through an extensive network of distributors and pharmacies, in addition to utilizing various online e-commerce pharmacy platforms.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q3 2025 | Feb 5, 2025 | ₹5.97 | ₹3.17B-5.47% vs estimate |
|---|
| Q2 2025 | Nov 7, 2024 | ₹6.10 | ₹3.18B-0.09% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹925.10-₹20.90 (-2.21%)
Jubilant Pharmova Limited’s quoted price sits in the lower half of its reported 52-week range, 21.8% below the high.
₹113.35-₹5.96 (-5.0%)
Morepen Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 24.78% below the high.
₹178.52-₹6.41 (-3.47%)
IOL Chemicals and Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 20.43% below the high.
₹517.05+₹31.25 (+6.43%)
SMS Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 1.58% below the high.
₹2,649.10-₹354.70 (-11.81%)
RPG Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 15.3% below the high.
₹836.95-₹56.45 (-6.32%)
Orchid Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 26.53% below the high.
₹87.24+₹7.50 (+9.41%)
Anuh Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 12.65% below the high.
₹136.44-₹0.10 (-0.07%)
ZIM Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 14.9% below the high.
